These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 10896252

  • 1. Heparin induces synthesis and secretion of tissue factor pathway inhibitor from endothelial cells in vitro.
    Hansen JB, Svensson B, Olsen R, Ezban M, Osterud B, Paulssen RH.
    Thromb Haemost; 2000 Jun; 83(6):937-43. PubMed ID: 10896252
    [Abstract] [Full Text] [Related]

  • 2. Bemiparin and fluid flow modulate the expression, activity and release of tissue factor pathway inhibitor in human endothelial cells in vitro.
    Westmuckett AD, Kakkar VV, Hamuro T, Lupu F, Lupu C.
    Thromb Haemost; 2001 Dec; 86(6):1547-54. PubMed ID: 11776326
    [Abstract] [Full Text] [Related]

  • 3. Impact of native VLDL on tissue factor pathway inhibitor in endothelial cells and interactions between TFPI and lipoprotein lipase.
    Brodin E, Iversen N, Hansen JB.
    J Lab Clin Med; 2006 Apr; 147(4):167-73. PubMed ID: 16581344
    [Abstract] [Full Text] [Related]

  • 4. Intravascular release and urinary excretion of tissue factor pathway inhibitor during heparin treatment.
    Brodin E, Svensson B, Paulssen RH, Nordoy A, Hansen JB.
    J Lab Clin Med; 2004 Nov; 144(5):246-53; discussion 226-7. PubMed ID: 15570242
    [Abstract] [Full Text] [Related]

  • 5. Relative quantification of glycosaminoglycan-induced upregulation of TFPI-mRNA expression in vitro.
    Thyzel E, Kohli S, Siegling S, Prante C, Kleesiek K, Götting C.
    Thromb Res; 2007 Nov; 119(6):785-91. PubMed ID: 16919311
    [Abstract] [Full Text] [Related]

  • 6. Effect of unfractionated heparin and a low molecular weight heparin (enoxaparin) on coagulant activity of cultured human endothelial cells.
    Martinez-Sales V, Vila V, Réganon E, Oms JG, Aznar J.
    Haematologica; 2003 Jun; 88(6):694-9. PubMed ID: 12801846
    [Abstract] [Full Text] [Related]

  • 7. Differential effect of the low-molecular-weight heparin, dalteparin, and unfractionated heparin on microvascular endothelial cell hemostatic properties.
    Vignoli A, Marchetti M, Balducci D, Barbui T, Falanga A.
    Haematologica; 2006 Feb; 91(2):207-14. PubMed ID: 16461305
    [Abstract] [Full Text] [Related]

  • 8. Lysophosphatidylcholine decreases the synthesis of tissue factor pathway inhibitor in human umbilical vein endothelial cells.
    Sato N, Kokame K, Miyata T, Kato H.
    Thromb Haemost; 1998 Jan; 79(1):217-21. PubMed ID: 9459350
    [Abstract] [Full Text] [Related]

  • 9. Fucoidan, as heparin, induces tissue factor pathway inhibitor release from cultured human endothelial cells.
    Giraux JL, Tapon-Bretaudière J, Matou S, Fischer AM.
    Thromb Haemost; 1998 Oct; 80(4):692-5. PubMed ID: 9798992
    [Abstract] [Full Text] [Related]

  • 10. Novel interactions between UFH and TFPI in children.
    Newall F, Johnston L, Summerhayes R, Lane G, Cranswick N, Monagle P, Ignjatovic V.
    Br J Haematol; 2010 Nov; 151(4):376-80. PubMed ID: 20880110
    [Abstract] [Full Text] [Related]

  • 11. Cellular effects of heparin on the production and release of tissue factor pathway inhibitor in human endothelial cells in culture.
    Lupu C, Poulsen E, Roquefeuil S, Westmuckett AD, Kakkar VV, Lupu F.
    Arterioscler Thromb Vasc Biol; 1999 Sep; 19(9):2251-62. PubMed ID: 10479670
    [Abstract] [Full Text] [Related]

  • 12. Plasma levels of total and free tissue factor pathway inhibitor (TFPI) as individual pharmacological parameters of various heparins.
    Alban S, Gastpar R.
    Thromb Haemost; 2001 May; 85(5):824-9. PubMed ID: 11372675
    [Abstract] [Full Text] [Related]

  • 13. Molecular weight-dependent influence of heparin on the form of tissue factor pathway inhibitor circulating in plasma.
    Alban S.
    Semin Thromb Hemost; 2001 Oct; 27(5):503-11. PubMed ID: 11668420
    [Abstract] [Full Text] [Related]

  • 14. Tissue factor pathway inhibitor production by human mesangial cells in culture.
    Yamabe H, Osawa H, Inuma H, Kaizuka M, Tamura N, Tsunoda S, Fujita Y, Shirato K, Onodera K.
    Thromb Haemost; 1996 Aug; 76(2):215-9. PubMed ID: 8865534
    [Abstract] [Full Text] [Related]

  • 15. [Antithrombotic mechanisms of holothurian glycosaminoglycan extracted from sea cucumber].
    Shen WZ, Zhou RF, Wang XF, Ding QL, Wang HL.
    Zhonghua Xue Ye Xue Za Zhi; 2006 Sep; 27(9):579-83. PubMed ID: 17278421
    [Abstract] [Full Text] [Related]

  • 16. Depletion of intravascular pools of tissue factor pathway inhibitor (TFPI) during repeated or continuous intravenous infusion of heparin in man.
    Hansen JB, Sandset PM, Huseby KR, Huseby NE, Nordøy A.
    Thromb Haemost; 1996 Nov; 76(5):703-9. PubMed ID: 8950777
    [Abstract] [Full Text] [Related]

  • 17. Plasmin proteolysis of endothelial cell and vessel wall associated tissue factor pathway inhibitor.
    Stalboerger PG, Panetta CJ, Simari RD, Caplice NM.
    Thromb Haemost; 2001 Sep; 86(3):923-8. PubMed ID: 11583328
    [Abstract] [Full Text] [Related]

  • 18. Different effects of enoxaparin and unfractionated heparin on extrinsic blood coagulation during haemodialysis: a prospective study.
    Naumnik B, Borawski J, Myśliwiec M.
    Nephrol Dial Transplant; 2003 Jul; 18(7):1376-82. PubMed ID: 12808176
    [Abstract] [Full Text] [Related]

  • 19. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells.
    Nadir Y, Brenner B, Gingis-Velitski S, Levy-Adam F, Ilan N, Zcharia E, Nadir E, Vlodavsky I.
    Thromb Haemost; 2008 Jan; 99(1):133-41. PubMed ID: 18217145
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of unfractionated heparin, low molecular weight heparin and both combined for releasing total and free tissue factor pathway inhibitor.
    Altman R, Scazziota A, Rouvier J.
    Haemostasis; 1998 Jan; 28(5):229-35. PubMed ID: 10420071
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.